Kohei Ogawa

Dr. Kohei Ogawa


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
RNRyosuke Nakamura
Ryosuke Nakamura
TOTakeshi Ozeki
Takeshi Ozeki
NHNoriaki Hirayama
Noriaki Hirayama
ASAkihiro Sekine
Akihiro Sekine
TYTaiki Yamashita
Taiki Yamashita
EMEishin Morita
Eishin Morita


15 February 2019 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
KIKentaro Iwasa
Kentaro Iwasa
KOKohei Ogawa
Kohei Ogawa
HAHiroaki Azukizawa
Hiroaki Azukizawa
HTHiroshi Tanabe
Hiroshi Tanabe
TITomoyuki Iwanaga
Tomoyuki Iwanaga
HAHideo Asada
Hideo Asada

25 June 2021 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AMAsuka Mori
Asuka Mori
SSSatoru Shinkuma
Satoru Shinkuma
YMYasuhiro Mitsui
Yasuhiro Mitsui
KOKohei Ogawa
Kohei Ogawa
FMFumi Miyagawa
Fumi Miyagawa
HAHideo Asada
Hideo Asada

1 January 2021 in Journal of Clinical and Experimental Hematopathology
Verified
Journal Article
Open access
PDF file
HIHiroe Itami
Hiroe Itami
HNHirokazu Nakamine
Hirokazu Nakamine
MKMasayuki Kubo
Masayuki Kubo
KOKohei Ogawa
Kohei Ogawa
RTRina Tani
Rina Tani
COChiho Ohbayashi
Chiho Ohbayashi
Intravascular large B-cell lymphoma (IVLBCL) is defined by the World Health Organization (WHO) Classification as one type of extranodal large B-cell lymphoma and it is characterized by the selective growth of lymphoma cells within blood vessels with minimal extravascular invasion. According to the criteria, however, several reported cases of IVLBCL with significant extravascular invasion cannot be classified as IVLBCL. The purpose of the present study was to assess the clinicopathological significance of the WHO criteria for IVLBCL. We characterized clinical, histopathological, and immunohistochemical features of 11 patients with extranodal diffuse large B-cell lymphoma (DLBCL) with significant intravascular invasion (DLBCL-IV), and statistically compared their features with those of 11 patients with IVLBCL and 15 patients with extranodal DLBCL with virtually no intravascular invasion (DLBCL-noIV). When compared with the DLBCL-noIV group, the DLBCL-IV group was characterized by significantly higher rates of splenomegaly, hemophagocytosis, advanced stage disease, and CD5 expression; higher average platelet count, serum lactate dehydrogenase level, and serum ferritin level. Progression-free survival was significantly shorter in the DLBCL-IV group than the DLBCL-noIV group. In contrast, there were no significant differences in clinicopathological features between the DLBCL-IV and the IVLBCL groups. Our study suggests that DLBCL-IV should be regarded as IVLBCL-related.

30 April 2016 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
KOKohei Ogawa
Kohei Ogawa
TFTakaya Fukumoto
Takaya Fukumoto
MYMotoyuki Yoshida
Motoyuki Yoshida
YMYuka Matsumoto
Yuka Matsumoto
CSChinatsu Shobatake
Chinatsu Shobatake
HAHideo Asada
Hideo Asada